Picture of Verona Pharma logo

VRNA Verona Pharma Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Verona Pharma, fiscal year end - December 31st, millions except per share.

2017
December 31st
2018
December 31st
R2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M
Source:10-K10-K10-K
Standards:
USG
USG
USG
Status:
fx
Preliminary
fx
Preliminary
FinalFinalFinal
Net Income/Starting Line-40.6-65.1-55.6
Depreciation
Non-Cash Items1.4521.623.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.27-2.11-1.56
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities-42.9-45.1-33.3
Capital Expenditures-0.053-0.082-0.012
Purchase of Fixed Assets
Other Investing Cash Flow Items47.49.790
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities47.39.71-0.012
Financing Cash Flow Items0-12.9-6.85
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0192-6.12
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.18158-39.6

Or unlock with your email

Or unlock with your email